光学相干断层扫描血管造影技术在糖尿病视网膜病变评估中的应用进展

Abstract
Figure/Table
References
Related Citation (15)

[1]	Ogurtsova K, da Rocha F J D, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040[J].Diabetes Res Clin Pract, 2017,128:40-50.
[2]	中华医学会糖尿病学分会视网膜病变学组.糖尿病相关眼病防治多学科中国专家共识(2021年版)[J]. 中华糖尿病杂志,2021,13(11):1026-1042.
[3]	许厚银,郎胜坤.OCTA对糖尿病视网膜病变患者视网膜微血管检测[J]. 国际眼科杂志,2022,22(2):327-330.
[4]	陈丽,姜亚萍,张鑫,等. 糖尿病视网膜病变患者OCTA检查结果的定量分析[J]. 同济大学学报(医学版),2021,42(6):819-824.
[5]	Savastano M C,Rispoli M,Lumbroso B,et al. Fluorescein angiography versus optical coherence tomography angiography: FA vs OCTA Italian study[J].Eur J Ophthalmol, 2021,31(2):514-520.
[6]	Invernizzi A,Cozzi M,Staurenghi G.Optical coherence tomography and optical coherence tomography angiography in uveitis: a review[J].Clin Exp Ophthalmol, 2019, 47(3):357-371.
[7]	蒋正轩,桂衍超,管一鸣,等.OCT参数作为雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿疗效的预测指标[J].国际眼科杂志,2022,22(8):1339-1344.
[8]	Kalra G,Zarranz-Ventura J,Chahal R,et al.Optical coherence tomography (OCT) angiolytics: a review of OCT angiography quantitative biomarkers[J].Surv Ophthalmol, 2022, 67(4):1118-1134.
[9]	张占荣,臧冬晓,刘华,等.采用OCTA分析非增殖期糖尿病视网膜病变患者黄斑区血流密度[J].国际眼科杂志,2020,20(10):1780-1785.
[10]	陈沁,喻晓兵,戴虹.糖尿病患者黄斑区视网膜毛细血管形态的光相干断层扫描血管成像观察[J].中华眼底病杂志,2018,34(4):328-332.
[11]	Ehlers J P,Jiang A C,Boss J D,et al.Quantitative utra-widefield angiography and diabetic retinopathy severity: an assessment of panretinal leakage index, ischemic index and microaneurysm count [J].Ophthalmology, 2019, 126(11):1527-1532.
[12]	Thompson I A,Durrani A K,Patel S.Optical coherence tomography angiography characteristics in diabetic patients without clinical diabetic retinopathy[J]. Eye (Lond), 2019,33(4):648-652.
[13]	Ishibazawa A,Nagaoka T,Takahashi A,et al.Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study [J].Am J Ophthalmol, 2015, 160(1):35-44.
[14]	Hamada M,Ohkoshi K,Inagaki K,et al.Visualization of microaneurysms using optical coherence tomography angiography: comparison of OCTA en face, OCT B-scan, OCT en face, FA, and IA images [J].Jpn J Ophthalmol, 2018, 62(2):168-175.
[15]	Parravano M,Geronimo D,Scarinci F,et al.Diabetic microaneurysms internal reflectivity on spectral-domain optical coherence tomography and optical coherence tomography angiography detection [J].Am J Ophthalmol, 2017, 179:90-96.
[16]	中华医学会糖尿病学分会视网膜病变学组.糖尿病视网膜病变防治专家共识[J].中华糖尿病杂志,2018,10(4):241-247.
[17]	李淑婷,王相宁,杜新华,等.共焦激光扫描炫彩眼底成像与彩色眼底照相对糖尿病视网膜病变的检出比较[J]. 中华眼底病杂志,2018,34(4):338-342.
[18]	Schaal K B, Munk M R, Wyssmueller I,et al.Vascular abnormalities in diabetic retinopathy assessed with swept-source optical coherence tomography angiography widefield imaging [J]. Retina, 2019,39(1):79-87.
[19]	Shimouchi A, Ishibazawa A, Ishiko S, et al. A proposed classification of intraretinal microvascular abnormalities in diabetic retinopathy following panretinal photocoagulation [J].Invest Ophthalmol Vis Sci, 2020,61(3):34.
[20]	高健,饶材花,刘伦. 重度糖尿病视网膜病变患者糖化血红蛋白控制水平与眼底黄斑区微血管变化的定量分析[J]. 临床眼科杂志,2021,29(4):289-293.
[21]	Pan J, Chen D, Yang X, et al. Characteristics of neovascularization in early stages of proliferative diabetic retinopathy by optical coherence tomography angiography[J].Am J Ophthalmol, 2018,192:146-156.
[22]	Khalid H,Schwartz R,Nicholson L,et al. Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy[J].Br J Ophthalmol, 2021,105(1):118-123.
[23]	Jia Y,Bailey S T,Hwang T S,et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye[J].Proc Natl Acad Sci USA, 2015, 112(18):2395-2402.
[24]	Shiihara H,Terasaki H,Sonoda S,et al. Objective evaluation of size and shape of superficial foveal avascular zone in normal subjects by optical coherence tomography angiography[J]. Sci Rep, 2018, 8(1):10143.
[25]	刁莉莉,史雪辉,张丛,等.糖尿病性黄斑水肿患者黄斑中心凹无血管区形态与视网膜光感受器层完整性的关系[J].眼科新进展,2020,40(1):38-41.
[26]	Dimitrova G,Chihara E,Takahashi H, et al. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy[J].Invest Ophthalmol Vis Sci,2017,58(1):190-196.
[27]	Hirano T,Kitahara J,Toriyama Y,et al. Quantifying vascular density and morphology using different swept-source optical coherence tomography angiographic scan patterns in diabetic retinopathy[J].Br J Ophthalmol, 2019, 103(2):216-221.
[28]	Tang F Y,Ng D S,Lam A,et al.Determinants of quantitative optical coherence tomography angiography metrics in patients with diabetes[J].Sci Rep,2017, 7(1):2575.
[29]	Wang G, Li M, Yun Z,et al.A novel multiple subdivision-based algorithm for quantitative assessment of retinal vascular tortuosity[J].Exp Biol Med (Maywood), 2021, 246(20):2222-2229.
[30]	Cao D,Yang D,Huang Z,et al.Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy[J].Acta Diabetol, 2018, 55(5):469-477.
[31]	Yasin A A,Moult E M, Shahzad R,et al.Quantifying microvascular changes using oct angiography in diabetic eyes without clinical evidence of retinopathy[J].Ophthalmol Retina, 2018, 2(5):418-427.
[32]	Sun Z,Tang F,Wong R,et al.OCT Angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema: a prospective study[J].Ophthalmology, 2019,126(12):1675-1684.
[33]	Kim A Y,Chu Z,Shahidzadeh A,et al.Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography[J].Invest Ophthalmol Vis Sci, 2016, 57(9):362-370.
[34]	Tang F Y,Chan E O,Sun Z,et al.Clinically relevant factors associated with quantitative optical coherence tomography angiography metrics in deep capillary plexus in patients with diabetes[J].Eye Vis (Lond), 2020, 7:7.
[35]	Johannesen S K,Viken J N,Vergmann A S,et al.Optical coherence tomography angiography and microvascular changes in diabetic retinopathy: a systematic review[J].Acta Ophthalmol, 2019, 97(1):7-14.
[36]	Toto L,D'Aloisio R,Di Nicola M,et al. Qualitative and quantitative assessment of vascular changes in diabetic macular edema after dexamethasone implant using optical coherence tomography angiography [J].Int J Mol Sci, 2017, 18(6):1181.
[37]	Carlo T E,Chin A T,Joseph T,et al.Distinguishing diabetic macular edema from capillary nonperfusion using optical coherence tomography angiography [J].Ophthalmic Surg Lasers Imaging Retina,2016, 47(2):108-114.
[38]	Lee J,Moon B G,Cho A R,et al.Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response[J].Ophthalmology, 2016, 123(11):2368-2375.
[39]	Ran A R,Cheung C Y,Wang X,et al.Detection of glaucomatous optic neuropathy with spectral-domain optical coherence tomography: a retrospective training and validation deep-learning analysis[J].Lancet Digit Health, 2019, 1(4):e172-e182.
[40]	Milea D,Najjar R P,Zhubo J,et al.Artificial intelligence to detect papilledema from ocular fundus photographs[J].N Engl J Med, 2020, 382(18):1687-1695.
[41]	Guo Y,Camino A,Wang J,et al.MEDnet, a neural network for automated detection of avascular area in OCT angiography [J].Biomed Opt Express, 2018, 9(11):5147-5158.
[42]	Guo Y,Hormel T T,Xiong H,et al.Development and validation of a deep learning algorithm for distinguishing the nonperfusion area from signal reduction artifacts on OCT angiography [J].Biomed Opt Express, 2019, 10(7):3257-3268.